1-8 of 8
Beatriz Sanchez Espiridion
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with High Risk or Refractory/Relapsed Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation

Gheath Alatrash, Cristina Knape, Laura Whited, Dawen Sui, Cara L Haymaker, Jason Yeh, Megan Marcotulli, Pariya Sukhumalchandra, Lisa St. John, Hsinyi Lu, Daniela E. Duenas, Ignacio Wistuba, Julia Mendoza Perez, Beatriz Sanchez Espiridion, Roland L. Bassett, Tapan M. Kadia, Courtney D. DiNardo, Farhad Ravandi, Jeremy Ramdial, Rohtesh S. Mehta, Amin M. Alousi, Betul Oran, Issa F. Khouri, Qaiser Bashir, Chitra Hosing, Muzaffar H. Qazilbash, Jin S. Im, Partow Kebriaei, Pavan Bachireddy, Jeffrey J. Molldrem, Jeffrey L. Jorgensen, Sa A. Wang, Wei WANG, Uday Popat, Elizabeth J. Shpall, Richard E. Champlin, Hagop M. Kantarjian, Naval Daver
Journal: Blood
Blood (2024) 144 (Supplement 1): 1047.
https://doi.org/10.1182/blood-2024-211343
Published: 2024
Journal Articles

Blast MRD AML-2: Blockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease (MDR) in Acute Myeloid Leukemia (AML) 2- a Randomized Phase 2 Study of the Venetoclax, Azacitidine, and Pembrolizumab Versus Venetoclax and Azacitidine As First Line Therapy in Older Patients with AML Who Are Ineligible or Who Refuse Intensive Chemotherapy

Amer M. Zeidan, MBBS, MHS, Prajwal Boddu, MD, Brent L Wood, MD PhD, Daniel Zelterman, Richard F. Little, MDMPH, S. Percy Ivy, MD, Anne Caldwell, Beatriz Sanchez-Espiridion, Gheath Alatrash, Elad Sharon, MD MPH, Jerald P. Radich, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-139752
Published: 2020
Journal Articles

Blast MRD AML-1 Trial: Blockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia (AML) 1- an Investigator-Initiated, CTEP-Sponsored, Randomized Phase 2 Study of the Anti-PD-1 Antibody Pembrolizumab in Combination with Conventional Intensive Chemotherapy (IC) As Frontline Therapy in Patients with Acute Myeloid Leukemia (AML)

Amer M. Zeidan, MBBS, MHS, Prajwal C Boddu, MBBS, Brent L Wood, MD PhD, Daniel Zelterman, Richard F. Little, MDMPH, S. Percy Ivy, MD, Anne Caldwell, Beatriz Sanchez-Espiridion, Gheath Alatrash, Elad Sharon, MD MPH, Jerald P. Radich, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15.
https://doi.org/10.1182/blood-2020-139668
Published: 2020
Journal Articles

Inflammation Induces Hematopoietic Stem Cell/Progenitor Migration and Recruitment To Lymph Nodes In Mice and Humans

Juana Serrano, PhD, Josefina Serrano, Kyung-Hee Chang, PhD, Yami Rangel, MD, Beatriz sanchez-Espiridion, PhD, Ashley Ficker, Jose A. Cancelas, M.D. PhD., Joaquin sanchez-Garcia, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1030.
https://doi.org/10.1182/blood.V122.21.1030.1030
Published: 2013
Journal Articles

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy

Santiago Montes-Moreno, Nerea Martinez, Beatriz Sanchez-Espiridión, Ramon Díaz Uriarte, Maria Elena Rodriguez, Anabel Saez, Carlos Montalbán, Gonzalo Gomez, David G. Pisano, Juan Fernando García, Eulogio Conde, Eva Gonzalez-Barca, Andres Lopez, Manuela Mollejo, Carlos Grande, Miguel Angel Martinez, Cherie Dunphy, Eric D. Hsi, Gabrielle B. Rocque, Julie Chang, Ronald S. Go, Carlo Visco, Zijun Xu-Monette, Ken H. Young, Miguel A. Piris
Journal: Blood
Blood (2011) 118 (4): 1034–1040.
https://doi.org/10.1182/blood-2010-11-321554
Published: 2011
Includes: Supplemental data
Journal Articles

Mirna EXPRESSION SIGNATURES as PROGNOSTIC Markers IN ADVANCED Classical HODGKIN LYMPHOMA

Beatriz Sanchez-Espiridion, Carlos Montalban ESQ, MD, PhD, Pablo Guisado, Maria E. Rodriguez, Miguel Canales, Javier Alves, Francisco Vega, MD, PhD, Manuel Morente, José Francisco Tomás, Miguel A. Piris, Juan F. Garcia
Journal: Blood
Blood (2010) 116 (21): 4157.
https://doi.org/10.1182/blood.V116.21.4157.4157
Published: 2010
Journal Articles

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

e-blood
Beatriz Sánchez-Espiridión, Carlos Montalbán, Ángel López, Javier Menárguez, Pilar Sabín, Carmen Ruiz-Marcellán, Andrés Lopez, Rafael Ramos, Jose Rodríguez, Araceli Cánovas, Carmen Camarero, Miguel Canales, Javier Alves, Reyes Arranz, Agustín Acevedo, Antonio Salar, Sergio Serrano, Águeda Bas, Jose M. Moraleda, Pedro Sánchez-Godoy, Fernando Burgos, Concepción Rayón, Manuel F. Fresno, José García Laraña, Mónica García-Cosío, Carlos Santonja, Jose L. López, Marta Llanos, Manuela Mollejo, Joaquín González-Carrero, Ana Marín, Jerónimo Forteza, Ramón García-Sanz, Jose F. Tomás, Manuel M. Morente, Miguel A. Piris, Juan F. García, on behalf of the Spanish Hodgkin Lymphoma Study Group
Journal: Blood
Blood (2010) 116 (8): e12–e17.
https://doi.org/10.1182/blood-2010-02-270009
Published: 2010
Journal Articles

An Enriched Multigen Low-Density Array To Predict Outcome in Advanced Hodgkin Lymphoma Paraffin-Embedded Samples.

Beatriz Sanchez-Espiridion, Abel Sanchez-Aguilera, PhD., Carlos Montalban, Monica Garcia-Cosio, Carmen Bellas, Vicente Romagosa, Javier Menarguez, Manuel F. Fresno, Jose F. Tomas, Manuel M. Morente, MD phD., Miguel A. Piris, MD phD., Juan F. Garcia, MD. phD.
Journal: Blood
Blood (2007) 110 (11): 383.
https://doi.org/10.1182/blood.V110.11.383.383
Published: 2007